EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Products in the Treatment of Retinopathy of Prematurity: Exploring Therapeutic Potentials

Jong-Ik Heo, Juhee Ryu iD

International Journal of Molecular Sciences · 02.08.2024 · 25 (15) · 8461

DOI: 10.3390/ijms25158461 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.08.2024. Verfasst von Jong-Ik Heo und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Biological Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyungpook National University, Kyungpook National University Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinopathy of prematurity (ROP) is a vascular disorder affecting the retinas of preterm infants. This condition arises when preterm infants in incubators are exposed to high oxygen levels, leading to oxidative stress, inflammatory responses, and a downregulation of vascular endothelial growth factors, which causes the loss of retinal microvascular capillaries. Upon returning to room air, the upregulation of vascular growth factors results in abnormal vascular growth of retinal endothelial cells. Without appropriate intervention, ROP can progress to blindness. The prevalence of ROP has risen, making it a significant cause of childhood blindness. Current treatments, such as laser therapy and various pharmacologic approaches, are limited by their potential for severe adverse effects. Therefore, a deeper understanding of ROP’s pathophysiology and the development of innovative treatments are imperative. Natural products from plants, fungi, bacteria, and marine organisms have shown promise in treating various diseases and have gained attention in ROP research due to their minimal side effects and wide-ranging beneficial properties. This review discusses the roles and mechanisms of natural products that hold potential as therapeutic agents in ROP management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinopathy of PrematurityBiological ProductsHumansInfant, NewbornAnimalsInfant, Premature

Stichwörter der Autor:innen

angiogenesisnatural productsretinal vascular diseaseretinopathy of prematurity

Substanzen

Biological Products

Autor:innen und Institutionen

  • College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.

ORCID-Profile: Juhee Ryu

Förderung

  • Kyungpook National University
  • Kyungpook National University Research Fund

Zitieren

APA

Heo, J. I., & Ryu, J. (2024). Natural Products in the Treatment of Retinopathy of Prematurity: Exploring Therapeutic Potentials. International Journal of Molecular Sciences, 25(15), 8461. https://doi.org/10.3390/ijms25158461

Vancouver

Heo JI, Ryu J. Natural Products in the Treatment of Retinopathy of Prematurity: Exploring Therapeutic Potentials. International Journal of Molecular Sciences. 2024;25(15):8461. doi:10.3390/ijms25158461

BibTeX
@article{Heo2024,
  author = {Heo, Jong-Ik and Ryu, Juhee},
  title = {Natural Products in the Treatment of Retinopathy of Prematurity: Exploring Therapeutic Potentials},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {15},
  pages = {8461},
  doi = {10.3390/ijms25158461}
}
Kostenlos starten →